Dr. Kevin Chuen Wing Chan is an Associate Professor of Ophthalmology and the Director of the Neuroimaging and Visual Science Laboratory at Stanford University School of Medicine. Dr. Chan's laboratory focuses on developing and applying new, non-invasive methods for imaging neurodegeneration, neurodevelopment, neuroprotection, neuroplasticity, and neuroregeneration in vision-related diseases and injuries to guide vision preservation and restoration.

Dr. Rongxin Fang received his Ph.D. in Bioinformatics and Systems Biology at UC San Diego, where he was advised by Bing Ren (2015-2019). During this time, he developed high-throughput genomic technologies and computational tools to map the structure and activity of the mammalian genome at a large scale with single-cell resolution.

Dr. Sabine Heitzeneder’s research bridges the rational discovery of promising, tumor-restricted target antigens expressed on childhood cancer, that are absent from normal, vital tissue in the body and the robust pre-clinical development of adoptive cellular immunotherapies tailored to these antigens, that are suitable for phase I clinical testing in patients. 

Shannon received her B.S. in Chemistry from National Taiwan University. She then pursued her Ph.D. in Chemistry at UC Berkeley with Prof. Ignacio Tinoco, Jr. and studied ribosome translation dynamics (Cell 2015) using mass spectrometry and force spectroscopy with optical tweezers. During postdoc with Prof. Carlos Bustamante, also at UC Berkeley, Dr.

Dr. Maayan Levy received her Ph.D. in Immunology from the Weizmann Institute of Science. After completion of her PhD, Dr. Levy became an Assistant Professor at the Microbiology Department of the Perelman School of Medicine at the University of Pennsylvania. Dr. Levy has recently joined the Stanford Medicine Department of Pathology as an Assistant Professor and the Arc Institute as an Innovation Investigator in Residence.

Dr. Ximena Corso Díaz's lab is dedicated to uncovering mechanisms of gene regulation in neuronal cells with the goal of developing treatments for neurodegeneration. By studying the retina, a brain region responsible for light detection, they aim to identify molecular mechanisms that regulate neuronal gene expression programs and develop strategies to prevent blindness. 

Dr. Michael Fredericson is the first physician promoted to Professor of Physical Medicine & Rehabilitation (PM&R) at Stanford University and is currently Director of PM&R Sports Medicine in the Department of Orthopaedic Surgery, Co-Director of the Stanford Longevity Center, and Founder of Lifestyle Medicine. He is also the Head Team Physician for the Stanford Track & Field and Swimming Teams and a Wu Tsai Human Performance Alliance member.

Dr. Elisabetta Puglisi's group focuses on the role of RNA conformation in viral infection. Primary systems are HIV and Dengue virus, where they investigate how RNA conformational plasticity mediates key aspects of viral replication.

Dr. Harris's research focuses on Rehabilitation of the Neuro-Axis and specific focus on precision care and management of sub populations.

While keeping the patients and families foremost in mind, Dr. John Day's research seeks to: define and understand genetic causes; clarify the molecular and cellular consequences of genetic change; determine the multisystemic features that are underappreciated but clinically significant consequence of these diseases; develop and improve methods for managing and treating each disease.